Protara Therapeutics Stock (NASDAQ: TARA) stock price, news, charts, stock research, profile.
You can purchase shares of Protara Therapeutics (NASDAQ:TARA) through any online brokerage.
Other companies in Protara Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Adaptimmune Therapeutics (NASDAQ:ADAP), Kyverna Therapeutics (NASDAQ:KYTX), TScan Therapeutics (NASDAQ:TCRX) and Lexeo Therapeutics (NASDAQ:LXEO).
Protara Therapeutics has a consensus price target of $22.50.
The stock price for Protara Therapeutics (NASDAQ: TARA) is $4 last updated February 20, 2025 at 6:26 PM EST.
There are no upcoming dividends for Protara Therapeutics.
Protara Therapeutics’s Q1 earnings are confirmed for Thursday, May 1, 2025.
There is no upcoming split for Protara Therapeutics.
Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.